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Introduction
The normal patterning and morphological development
requires precise coordination of cell proliferation,
differentiation, and programmed cell death. Several apoptotic
pathways are active during development, the mitochondrial
pathway being the best defined. This pathway is initiated when,
upon receipt of a death signal, cytochrome c is released through
the outer mitochondrial membrane to the cytoplasm where it
interacts with the apoptotic protease activating factor 1
(Apaf1). Apaf1 activates caspase 9 in the context of a
multiprotein complex termed the apoptosome. The
apoptosome in turn activates downstream caspases, mainly
caspase 3, involved in the proteolytic destruction of the cell
(reviewed by Sanders and Wride, 1995; Cecconi and Gruss,
2001). Members of the Bcl2 family are known to either
promote or inhibit apoptosis in response to a variety of cell
death signals. The anti-apoptotic isoform produced from the
Bcl2-like (Bcl2l) gene (formerly previously known as BclX),
Bcl-XL and Bcl2 can inhibit apoptosis, at least in part, by
blocking cytochrome c release, thus preventing apoptosome
formation (Kluck et al., 1997; Yang et al., 1997). Bcl2 can also
regulate the activation of caspase 2 independently of the
apoptosome (Marsden et al., 2002). Pro-apoptotic factors such
as Bax, Bad and Bak are known to block the anti-apoptotic
effects of Bcl-XL and Bcl2 through heterodimerization
(reviewed by Yuan and Yankner, 2000). To add to the
complexity, Bcl2l may be alternatively spliced to produce a
pro-apoptotic isoform, Bcl-XS, and several anti-apoptotic Bcl2
family members are known to be modulated by protease
cleavage that produces C-terminal peptides with pro-apoptotic
activity (Basañez et al., 2001; Clem et al., 1998; Fujita et al.,
1998). Although the major players in the cytochrome c-
dependent apoptotic cascade have been identified, the
individual contribution of each component to the development
of different organs is largely unknown.
The mammalian inner ear includes specialized vestibular
sensory organs for balance and a coiled cochlea for hearing.
The early development of the inner ear involves invagination
During inner ear development programmed cell death
occurs in specific areas of the otic epithelium but the
significance of it and the molecules involved have remained
unclear. We undertook an analysis of mouse mutants in
which genes encoding apoptosis-associated molecules have
been inactivated. Disruption of the Apaf1 gene led to a
dramatic decrease in apoptosis in the inner ear epithelium,
severe morphogenetic defects and a significant size
reduction of the membranous labyrinth, demonstrating
that an Apaf1-dependent apoptotic pathway is necessary
for normal inner ear development. This pathway most
probably operates through the apoptosome complex
because caspase 9 mutant mice suffered similar defects.
Inactivation of the Bcl2-like (Bcl2l) gene led to an overall
increase in the number of cells undergoing apoptosis but
did not cause any major morphogenetic defects. In
contrast, decreased apoptosis was observed in specific
locations that suffered from developmental deficits,
indicating that proapoptotic isoform(s) produced from
Bcl2l might have roles in inner ear development. In
Apaf1–/–/Bcl2l–/– double mutant embryos, no cell death
could be detected in the otic epithelium, demonstrating that
the cell death regulated by the anti-apoptotic Bcl2l isoform,
Bcl-XL in the otic epithelium is Apaf1-dependent.
Furthermore, the otic vesicle failed to close completely in
all double mutant embryos analyzed. These results indicate
important roles for both Apaf1 and Bcl2l in inner ear
development.
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of the ectodermal placode and its closure to form the otic
vesicle. Soon after closure, the otic epithelium undergoes a
sequence of complex morphogenetic events to form the
membranous labyrinth. The endolymphatic duct extends
dorsally and the cochlear duct grows ventrally. The utricle and
saccule are separated from each other and from the cochlear
duct through deepening constrictions in the ventral vestibular
part, whereas the dorsal portion develops into three
semicircular ducts through a multi-step process. These ducts
first emerge as bilayered epithelial outpocketings. The two
opposing layers then approach each other and form a so-called
fusion plate, in which the cells first detach from the underlying
basement membrane, intercalate and then disappear, creating
a hollow duct which further grows out to obtain its adult form
and size (Sher, 1971; Martin and Swanson, 1993). The periotic
mesenchyme develops in close contact with the otic
epithelium and forms the bony otic capsule to surround the
membranous labyrinth (Sher, 1971; Martin and Swanson,
1993).
Apoptotic cells have been detected in restricted areas of the
developing vertebrate inner ear. These areas include the
epithelial cells that transiently connect the surface ectoderm
and the otic vesicle during and after its closure, the base of the
outgrowing endolymphatic duct, a ventral area above the
primordium of the vestibulocochlear ganglion and the ventro-
medial wall of the growing cochlear duct (Marovitz et al.,
1976; Marovitz et al., 1977; Represa et al., 1990; Fekete et al.,
1997; Nikolic et al., 2000). In chicken embryos, apoptosis has
also been detected in the fusion plates of the semicircular ducts
(Fekete et al., 1997). Apoptosis at the fusion plates has not
been detected in mouse or human embryos (Martin and
Swanson, 1993; Nishikori et al., 1999).
Although the anatomic distribution of apoptotic cells in the
inner ear has been described, the molecular pathways
regulating programmed cell death in this structure have not
been studied in detail. The Apaf1 mutant mice die usually
perinatally (Cecconi et al., 1998; Yoshida et al., 1998). A few
postnatal survivors show a hyperactive behavior that was
suspected to be a consequence of inner ear defects, because
the brain of these mice appeared completely normal
(Honarpour et al., 2000). Postnatal defects have been reported
in the inner ear of caspase 3 mutant mice (Takahashi et al.,
2001). Here we undertook an analysis of Apaf1, Bcl2l and
caspase 9 mutant mice in order to gain insight into the
molecular mechanisms controlling cell death during inner ear
morphogenesis. We observed that the majority of the cell
death in the inner ear was Apaf1-dependent and most probably
occurred through the Apaf1/caspase 9 apoptosome pathway.
The lack of apoptosis in Apaf1 mutant mouse embryos led
to widespread defects in epithelial morphogenesis and
outgrowth. In contrast, increased apoptosis in Bcl2l mutant
embryos had no major impact on morphogenesis. However,
developmental defects with the latter mutants co-localized
with a decrease of apoptosis.
Materials and methods
Mouse stocks and strains
The generation and genotyping of Apaf1–/–, Bcl2l–/– and caspase 9–/–
mice has been described previously (Motoyama et al., 1995; Kuida et
al., 1998; Cecconi et al., 1998; Salminen et al., 1998). The Apaf1 locus
contains a promoterless IRES-lacZ cassette and thus the expression
of the lacZ gene is under the control of Apaf1 transcription regulatory
elements. All mouse lines were backcrossed into the C57BL/6 genetic
background for at least 12 generations. To generate embryos deficient
in both Apaf1 and Bcl2l, double heterozygous animals were interbred.
The embryos were taken from timed matings and the day on which a
vaginal plug was detected was assigned as E0.5.
Histological analysis and immunohistochemistry
For histological analysis serial paraffin sections through the inner
ear were stained with Hematoxylin and Eosin or Giemsa.
Immunohistochemical detection of activated caspase 3 was performed
with the rabbit anti-CM1 antibody as before (Cecconi et al., 1998).
For Bcl-XL immunostaining with mouse anti-Bcl-XL (H-5) antibody
(Santa Cruz), Bouin’s-fixed paraffin sections were deparafinized and
boiled for 20 minutes in 10 mM Citrate buffer (pH 6). After secondary
antibody (donkey anti-mouse HRP IgG) treatment, the signal was
amplified using the TSA Cyanine 3 System Kit (PerkinElmer Life
Science Products). BrdU intraperitoneal injection and detection in
proliferating cells were performed as before (Salminen et al., 2000).
Anti-class III b -tubulin (TUJ1, Babco) was used as a control antibody.
Three-dimensional reconstructions from histological sections of inner
ears at stage E13.5 were constituted from serial paraffin cross-sections
of 10 m m thickness. One ear from each genotype was used for
reconstruction and the embryos all came from the same litter of a
mating between two Apaf1/Bcl2l double heterozygous animals.
RNA isolation and reverse transcription-polymerase chain
reaction (RT-PCR) assay
Total RNA was isolated with Trizol Reagent (Life Technologies) from
wild-type E9.5 and E11.5 mouse embryos. To detect the different
splice variants produced from the Bcl2l gene, 2 m g of the isolated
RNA was subjected to RT reaction using the RT-primer 5 ¢ -
GACTGAAGAGTGAGCCCAGATC-3¢ . The forward and reverse
primers for PCR were 5¢ -CAGTGAAGCAAGCGCTGAGAG-3¢ and
5¢ -CGTCAGAAACCAGCGGTTGAAG-3¢ , respectively.
RNA in situ hybridization and staining for b -galactosidase
activity
In situ hybridization and preparation of the radioactive antisense and
sense Netrin1 (Serafini et al., 1996), Pax2 (Dressler et al., 1990) and
Dlx5 (Acampora et al., 1999) probes were performed as described in
Salminen et al. (Salminen et al., 2000). Whole-mount lacZ staining
for E12.5 Apaf1+/– and –/– embryos was conducted as described in
Hogan et al. (Hogan et al., 1994).
Detection of apoptosis
Detection of apoptosis was performed with the in situ DNA-end
labeling technique, the TUNEL method, that detects DNA
fragmentation as an indicator of ongoing apoptosis. TUNEL analysis
was performed on 10 m m-thick paraffin sections with the ApopTag
Fluorescein In Situ Apoptosis Detection Kit (Intergen). The
proportion of TUNEL-positive cells from all otic vesicle cells was
calculated on serial sections of 2 or 3 E9.5, E10.5 or E12.5 embryos.
Results
Expression of Apaf1 and Bcl2l genes during inner
ear development
The expression of Apaf1 and Bcl2l was analyzed at various stages
during the early development. Apaf1/lacZ is widely expressed in
developing embryos heterozygous for the lacZ-containing allele
(Fig. 1L). A rather weak expression could be detected at E9.5-
10.5 all through the otic vesicle and in the periotic mesenchyme
developing into the otic capsule (Fig. 1A,B). At E12.5 highest
levels of Apaf1/lacZ gene expression were observed in the
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endolymphatic duct epithelium. Expression could also be
detected in the periotic mesenchyme and it was slightly elevated
in the tips of the semicircular ducts as well as in the cochlear duct
compared with the rest of the otic epithelium (Fig. 1D,E).
The Bcl2l gene has been shown to produce several protein
isoforms through alternative splicing (Bcl-XS) and cleavage of
the major anti-apoptotic Bcl-XL isoform (Clem et al., 1998;
Fujita et al., 1998). We detected the Bcl-XL isoform in the
developing inner ear with an isoform-specific antibody and
studied the expression of the alternatively spliced Bcl-XS
isoform with RT-PCR assay. To our knowledge, antibodies
specific for cleaved Bcl-XL protein isoforms are unavailable.
Bcl-XL immunoreactivity was found all over the otic
epithelium at E10.5-12.5, but no protein could be detected
in the periotic mesenchyme (Fig. 1G-I). To analyze the
expression of the alternatively spliced Bcl-XS isoform we
performed RT-PCR reactions on total RNA isolated from E9.5
and E11.5 otic vesicle and periotic mesenchyme. The RT-PCR
primers were designed to hybridize to sequences common to
both Bcl-XL and Bcl-XS so that Bcl-XL-specific mRNA would
give a 395 bp-long fragment and Bcl-XS-specific mRNA a 206
bp-long fragment. As seen in Fig. 1N, only the Bcl-XL-specific
mRNA could be detected at E9.5 and E11.5.
Changes in apoptotic profiles at E9.5-10.5 in the
Apaf1 and Bcl2l mutant inner ears
We compared the pattern of programmed cell death in Apaf1
and Bcl2l mutant inner ears with the corresponding wild-type
littermates. In an early otic vesicle, at E9.5-10.0, a TUNEL-
positive cell cluster localized to the ventro-posterior area
(arrowhead Fig. 2B) and a few scattered dying cells could be
observed more dorsally. In Apaf1 mutant otic vesicles, no
apoptotic cells were detected at E9.5-10.5 (Fig. 2C and data
not shown). In Bcl2l mutant otic epithelium, a significant 3-
fold increase in the proportion of TUNEL-positive cells could
be observed (Fig. 2D, Table 1).
Many TUNEL-positive cells were detected at the base of
the wild-type endolymphatic duct at E10.5 (Fig. 2F). In the
posterior part of the otic vesicle apoptotic cells were spread
over a broad area extending dorsally (Fig. 2G). Anti-caspase 3
Fig. 1. Detection of Apaf1/lacZ and Bcl-XL in the developing inner ear at E12.5. Apaf1/lacZ expression could be detected in the otic epithelium
and the surrounding mesenchyme at E9.5 (A), E10.5 (B) and E12.5 (D,E). No staining could be detected in sections from wild-type embryos
(C). Bcl-XL protein could be detected in the otic epithelium but not in the periotic mesenchyme at E10.5 (G), E11.5 (H) and E12.5 (I). No
staining in the otic region could be detected in control sections with only secondary antibody (F) or with TUJ1 antibody which specifically
stains neurons (J). (K) Plane of the sections, (L) lacZ expression in a heterozygous Apaf1+/– embryo, (M) control staining in a wild-type
embryo. (N) RT-PCR analysis of total RNA from E9.5 and E11.5 wild-type embryos. Only a 395 bp-long fragment corresponding to the Bcl-XL
isoform was detected. Scale bar: 100 m m. a, anterior; c, cochlea; d, dorsal; ed, endolymphatic duct; ld, lateral semicircular duct; nt, neural tube;
ov, otic vesicle; p, posterior; pd, posterior semicircular duct; sd, superior semicircular duct; us, utriculosaccular space; v, ventral.
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staining showed a very similar spatial pattern of dying cells to
TUNEL (data not shown) but revealed far fewer cells. This
discrepancy may be because of the fact that activated caspase
3 is present only transiently in dying cells, whereas the DNA
breaks detected by the TUNEL assay persist for a longer
period.
A marked 3-fold increase in the ratio of TUNEL-positive
cells could be detected in the endolymphatic duct epithelium
of the Bcl2l mutant embryos at E10.5 (Table 1). In addition,
the distribution of dying cells in Bcl2l mutant ears extended
more ventrally (Fig. 2H). In the rest of the otic vesicle, a 2-
fold increase of TUNEL-positive cells could be observed
(Table 1). A cluster of apoptotic cells could be observed in the
ventro-posterior area of the Bcl2l mutant otic epithelium, but
the broad area of apoptotic cells observed more dorsally in the
wild-type otic vesicle (Fig. 2G) was not detected (Fig. 2H).
Extensive cell movement occurs in the otic epithelium after its
closure (Brigande et al., 2000) and thus, the lack of dying cells
in the dorsal wall of the Bcl2l mutant otic vesicle could be
because of premature death of these cells while still in a more
ventro-posterior location (Fig. 2B,D).
Apoptosis has been thought to be responsible for the
complete detachment of the mammalian otic vesicle from the
surface ectoderm by removing the connecting epithelial stalk
after the closure (Marovitz et al., 1976; Represa et al., 1990;
Lang et al., 2000). We observed a cluster of apoptotic cells
in the region between the surface ectoderm and the
endolymphatic duct epithelium in wild-type embryos at E9.5
and E10.5 (Fig. 2F and data not shown). In the Apaf1 mutant
embryos (n=3), this apoptotic group of cells could not be
observed but the otic vesicles had nevertheless closed normally
(Fig. 2C). In Bcl2l mutant embryos (n=3) no clear cluster of
apoptotic cells but instead a few scattered cells could be
observed in the closure region (Fig. 2H).
Very little or no apoptosis could be observed in the periotic
mesenchyme of the wild-type embryos (Fig. 2F,G). Apoptosis
could, however, be detected elsewhere in the head mesenchyme
(Fig. 2B,F). Also, no apoptosis could be observed in the
periotic mesenchyme of either Apaf1 or Bcl2l mutant embryos
(Fig. 2C,D,H).
Taken together, our results demonstrate that the normal
developmental apoptotic pattern had changed in both Apaf1
and in Bcl2l mutant inner ears. The almost complete lack of
apoptotic cells in the Apaf1 mutant ears indicates that the
majority of the apoptosis detected in the wild-type otic
epithelium at E9.5-10.5 is Apaf1-dependent. Inactivation of the
Bcl2l gene led to a general increase of cell death in the
expected apoptotic areas of the otic epithelium. This result is
probably because of the lack of the anti-apoptotic Bcl2l
isoform. However, at the closure site, a decrease of apoptotic
cell numbers was observed, suggesting that pro-apototic Bcl2l
isoforms might be active there.
Changes in the apoptotic pattern at E12.5
In wild-type embryos at E12.5, TUNEL-positive cells were
detected in the endolymphatic duct epithelium (Fig. 3A), the
wall of the cochlear duct (Fig. 3A-D), the distal edge of the
three semicircular duct epithelium (shown for the superior duct
in Fig. 3A-D, arrow in A) and the areas where the utricle,
saccule and the cochlear duct will be separated by deepening
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Table 1. Increase in cell death in Bcl2l mutant otic
epithelium 
Stage Wild type (%) Bcl2l–/– (%) P
E9.5 ov 14.4±5.4 41.9±10.9 <0.0001
E10.5 ed 25.5±11.3 77.2±8.8 <0.0001
E10.5 ov without ed 16.9±6.5 29.9±5.9 <0.0001
E12.5 ssd 25.8±6.7 52.0±8.6 <0.0001
The proportion of TUNEL-positive cells from all otic vesicle cells was
calculated on serial sections covering the whole vesicle at E9.5 or E10.5 (two
embryos each genotype at each stage). In case of E10.5 the otic vesicle (ov)
was divided in two areas: the endolymphatic duct (ed) and the rest of the
epithelium. At E12.5, the proportion of TUNEL-positive cells was calculated
in the tip of the outgrowing superior semicircular duct (ssd). The calculated
mean values are given with standard deviation (±s.d.). The differences
between wild-type and Bcl2l mutant values was analyzed using the two-tailed
Student’s t-test.
Fig. 2. Apoptosis during early otic
vesicle development. (A) Plane of the
sections. Dying cells were detected in
cross-sections through the otic vesicle at
E10.0 (B-D) and E10.5 (E-H) with the
TUNEL method. (E) Negative control
for TUNEL staining without terminal
deoxynucleotidyl transferase. The
genotypes of the embryos are indicated
in each case. The arrowheads in F and H
point to the dying cells observed
between the otic vesicle and the surface
ectoderm. A higher magnification of
this area is shown in the left-hand
corner in F and H. Scale bar: 50 m m.
2129Apoptosis in inner ear
constrictions (Fig. 3B, arrowheads). In addition, some apoptotic
cells were observed in the superior and posterior semicircular
duct epithelium prior to the fusion in the area that is destined
to form the fusion plate. A few dying cells were also detected
in the immediately adjacent periotic mesenchyme (Fig. 3A,G,
arrowheads). In accordance with previous observations (Martin
and Swanson, 1993), we could not detect any dying cells when
the two epithelial cell layers were opposed and fused (data not
shown). However, a few TUNEL-positive cells were observed
in the mesenchyme lining the small empty hole after the fusion
plate had been cleared (arrowheads in Fig. 3C,D). In general,
no or very little apoptosis occurred in other areas of the periotic
mesenchyme at this stage.
Very few or no TUNEL-positive cells could be observed in the
Apaf1 mutant (n=6) otic epithelium or the periotic mesenchyme.
Further away from the ear, in the head mesenchyme, apoptosis
could, however, be detected as in the wild-type embryos,
suggesting an Apaf1-independent mechanism for the removal of
these cells (Fig. 3E). In the Bcl2l mutant (n=6) ears, an overall
increase of TUNEL-labeled cells could be detected in the normal
locations of the otic epithelium (Fig. 3F). In the tips of the
outgrowing superior semicircular duct a 2-fold increase was
observed (Table 1). However, a local lack of apoptosis could be
observed in the future fusion plate epithelium and the adjacent
periotic mesenchyme of the posterior semicircular duct as
compared with the wild-type embryos (compare Fig. 3G,H,
arrowheads). No TUNEL-positive cells could be detected in the
Bcl2l mutant periotic mesenchyme (Fig. 3F,H).
In summary, our results suggest that very little or no Apaf1-
independent apoptosis occurs in the otic epithelium at E12.5.
In the Bcl2l mutant embryos a general increase of apoptosis
was observed as at earlier stages, except for the fusion plate
area of the posterior semicircular duct where a lack of
apoptotic cells was observed. Very little apoptosis can be
detected in the periotic mesenchyme, suggesting that apoptosis
is not critical for the formation of the otic capsule.
Three-dimensional reconstructions of the mutant
inner ears reveal specific morphogenetic defects
and reduced growth
The morphogenetic architecture of the membranous labyrinth
has been established by E13.5. To examine the morphology
of the epithelial labyrinths of the embryos at this stage we
reconstructed three-dimensional images from serial sections.
The reconstructions showed that both Apaf1 and Bcl2l mutant
ears were smaller than the wild-type ears and were reduced to
54% and 70%, respectively (Fig. 4A-C). The diameter of the
corresponding mutant heads were 86% and 77% of that of the
wild-type heads, respectively (data not shown), which could
explain the reduction in membranous labyrinth size in the case
of Bcl2l mutants but not in the case of Apaf1 mutants.
The lack of apoptosis in the Apaf1 mutant inner ear
epithelium led to severe abnormalities in morphogenesis (Fig.
4B). The inner ear epithelium appeared misshapen and there
were no clear borders between the different compartments. The
endolymphatic duct was not properly elongated and instead, an
enlarged sac-like structure could be seen. At later stages
(E16.5-18.5), dorsal extension of the endolymphatic duct could
be observed, but the diameter of the duct always remains larger
than in the wild-type embryos, and therefore no sac structure
could be distinguished (Fig. 5A-C and data not shown). The
two semicircular duct outpocketings that form first, the
superior and posterior, show a small clearing of the fusion plate
at E13.5 as seen also in Fig. 4E for the posterior duct. At this
stage, the lateral semicircular duct remained as a very small
outpocketing without visible cleared area in the middle. The
Fig. 3. Apoptosis in the inner
ear at E12.5. TUNEL-positive
cells in sections from wild-
type (A-D,G), Apaf1 (E) and
Bcl2l mutant (F,H) embryos.
The arrowheads in A, C and G
point to TUNEL-positive cells
at the future fusion plate-
forming epithelium and the
adjacent periotic mesenchyme.
The arrowheads in B point to
dying cells at the areas where
the ducts separating the utricle,
saccule and cochlear duct will
become thinner. The arrow in
A points to the TUNEL-
positive cells at the outer edge
of the semicircular duct. Scale
bar: 100 m m. hm, head
mesenchyme; s, saccule; u,
utricle.
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cochlear duct was much shorter and more immature in shape
compared with the wild-type duct.
The morphology of the Bcl2l mutant inner ear was rather
normal except for the posterior semicircular duct that does not
form at all. Instead, an outpocketing without epithelial fusion
or clearing in the middle could be observed (Fig. 4C,F). In
all nine Bcl2l mutant embryos analyzed at E13.0-13.5 the
posterior duct failed to form.
The three-dimensional reconstructions demonstrated that the
decrease of apoptosis in Apaf1 mutant embryos led to a growth
retardation and to defects in shaping or ‘sculpting’ the
membranous labyrinth. Bcl2l inactivation led only to a
restricted phenotype concerning the posterior semicircular
duct.
Superior semicircular duct formation is most
severely affected in Apaf1 mutant embryos
Some variation in the severity of the phenotype of the Apaf1
mutant ears could be observed when sections through the ears
of 16 E12.5-18.5 embryos were analyzed. General variability
in Apaf1 mutant phenotypes has been observed before. In the
case of brain, variation ranges from severely overgrown
nervous tissue to a completely normal-looking tissue (Cecconi
et al., 1998; Honarpour et al., 2000). We obtained embryos at
a ratio of 10/6 for severe/mild phenotypes judged according
to the brain overgrowth. The severity of the inner ear
morphological phenotype seemed to correlate to some extent
with that in the brain. The Apaf1 mutant inner ear in Fig. 4B,E
comes from an embryo with a highly overgrown and open
brain structure, whereas Fig. 5B,C shows the two
ears from an embryo with no obvious brain defects.
In embryos in which brain overgrowth was
extensive, the ear was often aberrantly positioned
directly ventrally from the neural tube instead of its
normal lateral position (Fig. 4E). In addition, the ear
had turned in a more horizontal position. However,
irrespective of the severity of the brain phenotype or
ear position, the inner ear epithelium was always
reduced except for the endolymphatic duct which
was always enlarged (Fig. 4B, Fig. 5B,C). In
addition, the superior semicircular duct was always
markedly reduced (Fig. 5B) and sometimes
completely absent (41%) even in embryos with no
detectable brain phenotype (asterisk in Fig. 5C). The
other two semicircular ducts always formed and a
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Fig. 4. Three-dimensional reconstructions of
the inner ear epithelium at E13.5. Otic
epithelium was reconstructed from serial
sections through wild-type (A), Apaf1 (B) and
Bcl2l (C) mutant inner ears. All three embryos
came from the same double heterozygous
mating. A lateral view is shown, dorsal is up,
ventral down. The Apaf1 ear has been turned so
that it corresponds to the two others.
Endolymphatic duct is indicated with a blue
color, the semicircular ducts with yellow, the
utricle and saccule with red and the cochlea
with an orange color. The white line shows the
plane of the section through the posterior duct
shown in D-F. The black dots indicate Netrin1
expression after RNA in situ hybridization in
D-F. Scale bars: 60 m m in A-C; 100 m m in D-F.
Fig. 5. Variability in Apaf1 and caspase 9 inner ear
phenotype. Cross-sections through the inner ear at E16.5
(A-C) and E13.5 (D-F). The images in B and C show
sections from the two ears from the same Apaf1 mutant
embryo with no brain phenotype. The lack of superior
semicircular duct is indicated with an asterisk in C. The
section in E comes from a caspase 9 mutant embryo with
a mild brain phenotype, and in F from an embryo with a
severe brain phenotype. Scale bar: 100 m m. cc, crus
commune.
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clearing of the fusion plates could be detected by E14.5 (Fig.
4E, Fig. 5B,C).
The periotic mesenchyme seems to develop normally as
judged from those Apaf1 mutant embryos that lived until
E16.5-18.5 (n=5). The mesenchymal cells closest to the otic
epithelium are destined to undergo cell death once the
main morphogenetic events have occurred to generate the
perilymphatic space between the membranous and bony
labyrinths. Interestingly, this late cell death seems to occur
normally in the absence of Apaf1 (Fig. 5A-C).
The inner ear phenotype in the caspase 9 mutant
embryos closely resembled that of Apaf1 mutants
The results from the analyses of Apaf1 mutant animals
emphasized the importance of Apaf1 for the developmental
apoptosis that occurs during otic epithelium morphogenesis. To
determine whether this cell death involves the apoptosome or
occurs through an apoptosome-independent pathway (Marsden
et al., 2002), we analyzed the inner ear phenotype in six
caspase 9 mutant embryos at E13.5-17.5.
The inner ear phenotype in caspase 9 mutant embryos
including morphogenetic changes (enlarged endolymphatic
duct), smaller size, reduced semicircular ducts and variation in
phenotype severity was very similar to that observed in Apaf1
mutant embryos (Fig. 5D-F and data not shown). As for other
organs affected, the caspase 9 phenotype appeared slightly
milder than the Apaf1 phenotype (Cecconi et al., 1998; Yoshida
et al., 1998; Kuida et al., 1998; Hakem et al., 1998). These
results support the idea that most of the cell death in the
developing inner ear occurs through the activation of the
apoptosome complex.
Dorso-ventral compartmentalization occurred
normally in Apaf1 and Bcl2l mutant otic epithelium
To verify whether the regionalization of the inner ear
epithelium occurred normally in Apaf1 and Bcl2l mutant inner
ears, we performed in situ hybridization analyses with marker
genes known to be specific for either dorsal or ventral parts of
the inner ear. The Dlx5 gene was expressed normally in the
dorsal vestibular part and in the endolymphatic duct of both
mutants (shown for wild-type and Apaf1 mutant in Fig. 6A,B).
Pax2 expression was detected ventrally along the utricular wall
and in the developing cochlear duct (shown for wild-type and
Bcl2l mutant in Fig. 6C,D). Netrin1 is specifically expressed
in the semicircular duct fusion-plate-forming epithelium and
after duct formation it remains expressed at the inner edge of
the duct epithelium (Salminen et al., 2000). In both Apaf1 and
Bcl2l mutant ears Netrin1 was expressed in the fusion plate-
forming cells as well as the newly formed ducts (Fig. 4D-F,
Fig. 6E-F). These results demonstrate that in spite of the
changes in apoptotic patterns, abnormal cell positional
identities could not be detected in the mutants.
Cell proliferation changes in Apaf1 and Bcl2l mutant
otic epithelium
In many cases, the Apaf1 membranous labyrinth was reduced
to almost half of the normal size at E13.5 (Fig. 4A,B). To verify
whether cell proliferation was affected to the same extent in
different parts of the epithelium, we performed BrdU injections
into pregnant females and stained sections from the obtained
embryos with an anti-BrdU antibody. We chose to analyze two
stages, E11.5 and E12.5, in which the epithelial outgrowth is
most active. To calculate the proliferation indexes we analyzed
sections from two wild-type and two mutant embryos at each
stage.
In the severely affected Apaf1 mutant embryos, the overall
size of the otic epithelium was clearly diminished already at
E11.5 (Fig. 7A,B). In these ears, 22.9%±5.5% of the cells were
proliferating in comparison with the wild-type ears in which
the proliferation index was 33.4%±4.9% (P<0.001, Student’s
t-test). At E12.5 the defect in the semicircular duct outgrowth
became evident (compare superior and lateral ducts in Fig.
7F,G). However, no clear difference in the proliferation index
could no longer be detected here (data not shown). The
consequence of a decrease in the proliferation index at an
earlier stage could be observed as a strong reduction in the
number of cells in the mutant duct area at later stages. At E12.5
the proliferation index in the cochlear duct was 40.4%±10.3%
in the Apaf1 mutant and 68.8%±13.6% (P<0.001) in the wild-
type (examples in Fig. 7G,H). Moreover, an almost complete
lack of proliferating cells was observed in the outer wall of the
turning cochlear duct (arrowheads in Fig. 7G,H). No clear
Fig. 6. Dorso-ventral
determination of the otic
epithelium. Radioactive in situ
hybridization analysis on cross-
sections through E11.5
(A,B,E,F) and E12.5 (C,D,G)
embryos. The embryos were
treated with Dlx5 (A,B), Pax2
(C,D) and Netrin1 (E,F) antisense probes and with Netrin1 sense
probe (G). Scale bar: 100 m m.
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change in the local cell proliferation could be observed in the
endolymphatic duct epithelium between wild-type and Apaf1
mutant embryos at E11.5 (data not shown).
Interestingly, the dramatic increase of apoptosis in the otic
epithelium of the Bcl2l mutant embryos did not seem to have
much of an effect on its final size at E13.5, suggesting that the
increased apoptosis stimulated a compensatory increase in cell
proliferation. To verify this we compared cell proliferation
in wild-type (46.1%±10.2%) and Bcl2l mutant otic vesicles
(55.7%±9.3%) at E10.5 and observed a significant increase in
proliferation (P<0.0001) in Bcl2l mutant inner ears (examples
in Fig. 7D,E). At this stage, no clear difference (p=0.42)
in the total number of otic epithelium cells could be
observed between wild-type (189.7±19.7 average number of
cells/section±s.d.) and Bcl2l mutant (184.5±15.5) embryos
(n=2). At later stages, no significant difference could be
observed in proliferation indexes, for example, in the tips of
the outgrowing semicircular ducts (data not shown). At E13.5
the mutant semicircular ducts appeared slightly thinner (Fig.
4A,C) and the number of cells (24.6±3.1) in cross-sections
through the superior duct of the Bcl2l mutant ears (n=2) was
26% smaller than in wild-type ones (33.2±3.9, P<0.0001).
Taken together, our results suggest that Apaf1-dependent
apoptosis might be required to achieve the normal level of cell
proliferation in the developing otic epithelium excluding the
area of the endolymphatic duct. Lack of apoptosis seemed to
especially affect the outgrowth of the semicircular and the
cochlear ducts. Furthermore, an increase in apoptosis in Bcl2l
mutant inner ears seems to result in an increase of proliferation
at early stages that could at least partially
compensate for the important loss of
cells through excess cell death.
Otic vesicle closure failed to
occur in Apaf1/Bcl2l double
mutant mice
In order to check whether the anti-
apoptotic Bcl2l and the pro-apototic
Apaf1 operated independently of each
other or through a common pathway
during inner ear development, we
generated double mutant embryos. These
embryos died at E12.5-13.0, similar to
the Bcl2l single mutants, and suffered
from a hematopoietic failure indicating
that the inactivation of Apaf1 cannot
inhibit the excessive cell death occurring
in the hematopoietic system when the
Bcl2l gene is inactivated (Motoyama
et al., 1995). Apaf1 deficiency did,
however, prevent the increased cell
death observed in immature neurons
throughout the embryonic Bcl2l-
deficient nervous system (Motoyama et
al., 1995) (data not shown). The same
observations have been reported by
Yoshida et al. (Yoshida et al., 2002).
We analyzed the inner ear phenotype
in three double mutant embryos at E11.5.
In none of the three cases did the otic
epithelium undergo massive apoptosis as
in Bcl2l mutants. Instead, no apoptosis could be detected, a
phenotype very similar to that of Apaf1 mutant inner ears (Fig.
8A-B). This result suggests that in contrast to the
hematopoietic system, the excess of cell death that results from
Bcl2l inactivation requires Apaf1 in the inner ear.
The epithelial morphogenesis of the inner ear in the double
mutant embryos occurred in a very similar way to that in Apaf1
mutants. However, the otic vesicle failed to close completely
in all the six mutant ears that were analyzed (Fig. 8B,D,
arrows). The imperfect closure may have led to the lack of any
morphologically detectable endolymphatic duct formation,
because normally the endolymphatic duct forms close to the
site where the closure has taken place. In other areas of the otic
vesicle the regionalization occurred normally and Netrin1,
Dlx5 and Pax2 expression could be detected in anticipated
areas (Fig. 8F-G and data not shown).
Discussion
Programmed cell death is required to shape the
membranous labyrinth
In Apaf1 mutant embryos, none or very few dying cells could
be observed in the otic epithelium leading to a malformed
membranous labyrinth in which different compartments were
not clearly defined. In addition, the endolymphatic duct
remained enlarged and no sac structure could be distinguished.
Therefore, the localized Apaf1-dependent apoptosis that
normally removes cells at the constriction sites and at the base
of the endolymphatic duct is required for the correct shaping
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Fig. 7. Cell proliferation in Apaf1 and Bcl2l mutant otic epithelium. Proliferating cells were
detected with an anti-BrdU antibody staining of the developing inner ear at E11.5 (A-C), at
E10.5 (D-E) and E12.5 (F-H) in wild-type (A,D,F,H), Apaf1 (B,G) and Bcl2l (E) mutant otic
epithelium. Control staining with secondary antibody only (C). Scale bar: 100 m m.
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of the organ. The inner ear phenotype of the caspase 9 mutant
embryos closely resembled that of Apaf1 mutants, strongly
suggesting that Apaf1 affects inner ear morphogenesis through
the apoptosome complex.
The morphogenesis of the three semicircular ducts is a
complex procedure, the main steps of which seem to be common
for all of them. However, targeted mutations of several genes
in mouse have shown selective defects in duct formation
and suggested that the formation of each duct might be
independently controlled by specific sets of genes (Fekete,
1999). Here we show that the inactivation of the Bcl2l gene
selectively affects the formation of the posterior semicircular
duct. This phenotype could be because of the observed lack of
local apoptosis at the fusion plate-forming epithelium and/or in
the adjacent periotic mesenchyme, suggesting that pro-apoptotic
Bcl2l isoforms may have a developmental role there. Fekete et
al. (Fekete et al., 1997) have shown that overexpression of the
Bcl2 gene in chicken embryos leads to a block of cell death that
most severely affects the posterior duct. These observations
suggest a special regulatory role for Bcl2 family members
concerning the development of the posterior duct of the two
species. Interestingly, Apaf1 also seems to be required especially
for one of the semicircular ducts; the growth of the superior duct
is most severely affected in Apaf1 mutant embryos.
Some variation of the Apaf1 mutant inner
ear development was observed and the severity
of the phenotype correlated with that observed
in the brain. Therefore, it is possible that a
severely overgrown hindbrain enhances the
aberrant ear phenotype. However, we observed
that the principal structural and growth defects
were present also in Apaf1 mutant embryos
where no brain phenotype could be detected.
Apoptosis and outgrowth of the inner
ear epithelium
Unneeded cells are removed by apoptosis
in many organs during development. The
phenomenon is most striking in brain where in
some areas nearly 50% of the cells are
eliminated (reviewed by D’Mello, 1998). In
Apaf1 mutant mice, there is a decrease in
apoptosis in many neuronal populations
including neural precursors. This results in an
increased amount of cells undergoing cell
division and to overgrowth of the brain mass
(Cecconi et al., 1998; Yoshida et al., 1998).
A balance between cell proliferation and
apoptosis also seems to play a critical role
during inner ear development. There are
regional differences in the proliferative activity
in the otic vesicle resulting in differential
outgrowth of the epithelium (Lang et al., 2000).
In some areas where cells undergo active
proliferation, dying cells are abundant. These
areas include the distal edges of the semicircular
ducts and the wall of the cochlear duct (Fekete
et al., 1997; Nicolic et al., 2000). In Apaf1
mutant embryos, a surprising size reduction of
the membranous labyrinth was already observed
at E11.5 and cell proliferation had diminished
by 10-30% depending on the area and stage analyzed. There was
an especially clear reduction in the elongation of the cochlear
duct and the outgrowth of the semicircular ducts. Therefore, the
morphogenetic defects observed in the cochlea and in the
semicircular ducts seem to be a consequence of decreased
proliferation together with decreased apoptosis.
How does the lack of apoptosis affect cell proliferation in
these outgrowing areas of the otic epithelium? Apoptosis might
stimulate proliferation through increasing locally the amount
of growth-promoting factors released to the environment. This
kind of passive release of functional factors into the
environment from dying cells has been described (Scaffidi et
al., 2002). Fibroblast growth factors (FGFs) are potential
candidates to promote otic growth because several of them are
expressed in the otic epithelium during its outgrowth period
(reviewed by Noramly and Graigner, 2002). Interestingly, a
subset of extracellular FGFs do not have any signal peptide and
it has been proposed that they could be released passively from
damaged cells (reviewed by Ornitz and Itoh, 2001).
In Bcl2l mutant inner ears a dramatic increase of apoptosis
was observed at certain locations at E9.5-10.5. The excess of
cell death seems to be at some extent compensated by an
increase in cell proliferation because the ear is not smaller than
in the wild-type littermates at this early stage. In mice with a
Fig. 8. Analysis of the inner ear in Apaf1–/–/Bcl2l–/– double mutant embryos. Many
TUNEL-positive cells could be observed in the otic epithelium of Bcl2l–/– embryos (A)
at E11.5. No apoptosis could be observed in the Apaf1–/–/Bcl2l–/– double mutant otic
epithelium (B). In the wild-type embryo, the superior semicircular duct has already
formed (C), whereas more immature morphogenesis can be observed in the
Apaf1–/–/Bcl2l–/– double mutant otic epithelium (D-E). The arrows in B and D point to
the closure defect in the double mutant otic vesicles. In situ hybridization analysis
shows Dlx5 (F) and Netrin1 (G) expression in the double mutant superior semicircular
duct outpocketing. Scale bar: 100 m m.
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targeted mutation in the Bcl2 gene an increase in apoptosis can
be observed during development of many organs. This leads to
a dramatic decrease in the overall size of some organs such as
spleen, kidney and thymus. However, some cell types in the
developing kidney, such as the epithelium and interstitium,
hyperproliferated, leading to increased numbers of these cell
types (Veis et al., 1993). Thus, it seems that in some organs
and cell types increased apoptosis may lead to
overproliferation and decreased apoptosis to a growth delay.
More direct molecular links between proliferation and cell
death have been proposed in several cell culture studies
involving caspases (reviewed by Guo and Hay, 1999; Los et
al., 2001; Mendelsohn et al., 2002) and Bcl2 family members
(Los et al., 2001). How Apaf1 and apoptosis affect cell
proliferation in the otic epithelium remains to be clarified.
Another open question is why the phenotypes in brain and ear
are so different. It may be because of the fact that the
neuroectodermal cells continue to proliferate by default in the
absence of cell death, whereas the ectodermal cells of placodal
origin do not seem to proliferate by default and might require
stimuli and signals from the neighboring dying cells in order
to proliferate normally.
Closure of the otic vesicle does not occur in the
absence of both Apaf1 and Bcl2l gene products
Apoptotic cells have been detected in the area of otic vesicle
closure in normal embryos. However, no defects related to the
closure were observed in Apaf1 or Bcl2l single mutant
embryos. Interestingly, when Apaf1 mutation was introduced
into the Bcl2l-deficient background, the otic vesicle closure
was incomplete in 100% of the mutants. These observations
suggest that Apaf1 and pro-apoptotic Bcl2l gene product(s)
may have redundant functions in controlling cell death at the
closure site. The function of pro-apoptotic Bcl2l gene
product(s) at the otic vesicle closure site is further supported
by the fact that we observed a reduction, rather than an
increase, in cell death at the otic vesicle closure site in Bcl2l
mutant embryos. The Apaf1–/–/Bcl2l–/– phenotype is the first
example of an otic vesicle closure defect in mouse mutants.
Interestingly, the otic epithelium compartmentalization seems
to occur despite its incomplete closure.
In conclusion, we show that Apaf1-dependent and Bcl-XL-
regulated apoptosis is critical for the normal morphological
development and the outgrowth of the otic epithelium.
Furthermore, we propose that, together with Apaf1, pro-
apoptotic Bcl-XL isoform(s) produced from cleavage of Bcl-
XL could play a role in otic vesicle closure and in the formation
of the posterior semicircular duct.
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